Relative Bioavailability of PM101 IV and Cordarone IV

NCT00420953 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2017-09-08

No results posted yet for this study

Summary

Determine the relative bioavailability of PM101 I.V. and Cordarone I.V.

Conditions

  • Healthy

Interventions

DRUG

Cordarone

Sponsors & Collaborators

  • Prism Pharmaceuticals

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-18
Primary Completion
2007-04-23
Completion
2007-04-23

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00420953 on ClinicalTrials.gov